Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz. roll-on (NDC 30775-052-03) and b) 4 fl. oz. tube (NDC 30775-052-04) Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004
Published August 30, 2023 · Recall initiated: August 2, 2023
Summary
FDA records drug Class II recall D-1091-2023, published August 30, 2023 and initiated August 2, 2023. Recalling firm: Parker Laboratories, Inc.; Status: Terminated; Reported quantity: 8; Lot: Lot #: a) A1221010, Exp. Date 12/9/2023, b) A1221011, Exp date 12/9/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Parker Laboratories, Inc.
- Distributor
- Nationwide within the United States, Singapore, Korea and Hong Kong
- Lot
- Lot #: a) A1221010, Exp. Date 12/9/2023, b) A1221011, Exp date 12/9/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARedux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.May 1, 2024
- FDATensive Conductive Adhesive Gel, Product Ref. 22-60. 12, 1 case contains 12 inner boxes with 50g tubesMarch 6, 2024
- FDAHelix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-onAugust 30, 2023
- FDAProtex Foaming Hand Sanitizer (Benzalkonium Chloride 0.13%), packaged in a) 2 fl oz/60 mL Pump bottles (NDCAugust 30, 2023
- FDAHelix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDCAugust 30, 2023
- FDAHelix CBD Clinical Cream (Menthol 7.4%), packaged in a)3 gm pouches (NDC30775-054-01), b)2 fl. oz. tubes (NDCAugust 30, 2023
Questions about this recall
Was Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz. roll-on (NDC 30775-052-03) and b) 4 fl. oz. tube (NDC 30775-052-04) Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004 recalled?
Yes. FDA published recall D-1091-2023 on August 30, 2023. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail